Latin American Institute of Biotechnology MECHNIKOV cares about the quality, effectiveness and safety of the products released and supplied to the market.

Institute MECHNIKOV has a system of regestering analysis for reports from health system workers, patients, distributors, and is actively monitoring information on the development of adverse reactions or lack of efficacy.

If you become aware of side effects that occurred after the application of products manufactured by Institute MECHNIKOV, we ask you to inform us by any way possible:

Securtiy monitoring reports
"Inactivated Split Influenza Vaccine"

• 2018 security monitoring REPORT
• 2017 security monitoring REPORT
• 2016 security monitoring REPORT